PBAC Releases May 2026 Update on Medicine Funding Decisions
11 Jun 2026
The Pharmaceutical Benefits Advisory Committee (PBAC) has released its May 2026 update, outlining its recent work on medicine funding assessments and related activities.
The update provides a summary of key actions taken during May 2026, including an intracycle meeting, engagement with stakeholders, and preparatory meetings held ahead of sub-committee discussions.
It also highlights ongoing processes involved in reviewing and assessing medicines for possible listing under the Pharmaceutical Benefits Scheme.
PBAC Releases May 2026 Update on Medicine Funding Decisions
Source: Pharmaceutical Benefits Advisory Committee (PBAC)
Categories
- MBS
- PBS
- The Department Of Health And Aged Care
- RACGP
- NIP
- AHPRA
- NSW Health
- Queensland Health
- Victoria Health
- Tasmania News
- Western Australia
- SA Health
- NT HEALTH
- Pharmacy Board Of Ahpra
- National Asthma Council
- NT
- AMA
- NACCHO
- BCNA
- Australian College Of Nurse Practitioners
- Asthma Australia
- LFA
- Palliative Care
- Primary Health Network
- AIHW
- Children's Health Queenland
- Kidney Health
- CHF
- MHC
- Gold Coast
- Tsa
- TGA
Popular Posts
Recent Posts
Tags
- Environmental health National Health and Climate Strategy environmental-health-national-health-and-climate-strategy